The impact of apolipoprotein E4 on cause of death in Alzheimer's disease

Neurology

Volumn 49, Issue 1, 1997, Pages 76-81

  Olichney, J M ^b,c   Sabbagh, M N ^c   Hofstetter, C R ^a   Galasko, D ^b,c   Grundman, M ^b   Katzman, R ^a   Thal, L J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; ISCHEMIC HEART DISEASE; LIFESPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE;

EID: 0030853883     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.49.1.76     Document Type: Article

References (49)

1. Katzman R. The prevalence and malignancy of Alzheimer's disease. Arch Neurol 1976;33:217-218.
2. Katzman R, Hill LR, Yu ESH, et al. The malignancy of dementia: predictors of mortality in clinically diagnosed dementia in a population survey of Shanghai, China. Arch Neurol 1994;51: 1220-1225.
3. Aronson MK, Ooi WL, Geva DL, Masur D, Blau A, Frishman W. Dementia: age-dependent incidence, prevalence and mortality in the old old. Arch Intern Med 1991;151:989-992.
4. Molsa PK, Martilla RJ, Rinne UK. Survival and cause of death in Alzheimer's disease and multi-infarct dementia. Acta Neurol Scand 1986;74:103-107.
5. Go RCP, Todorov AB, Elston RC, Constantinidis J. The malignancy of dementias. Ann Neurol 1978;3:559-561.
6. Wang HA, Whanger A. Brain impairment and longevity. In: Palmore E, Jeffers FC, eds. Prediction of life span. Lexington, MA: DC Health, 1971:95.
7. Burns A, Jacoby R, Luthert P, Levy R. Cause of death in Alzheimer's disease. Age Aging 1990;19:341-344.
8. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-1472.
9. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of Apolipoprotein type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993;261:921-923.
10. Basun H, Grut M, Winblat B, Lannfelt L. Apolipoprotein ∈4 allele and disease progression in patients with late-onset Alzheimer's disease. Neurosci Lett 1995;183:32-34.
11. Gomez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E ∈4 in Alzheimer's disease. Ann Neurol 1996;39:62-70.
12. Corder EH, Saunders AM, Strittmatter WJ, et al. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease. Neurology 1995;45:1323-1328.
13. Schmechel DE, Saunders AM, Strttmatter WJ, et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease. Proc Nat Acad Sci USA 1993;90:9649-9653.
14. Olichney JM, Hansen LA, Galasko D, et al. The apolipoprotein E ∈4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 1996;47:190-196.
15. Schacter F, Faure-Delanef L, Guenot F, et al. Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994;6:29-32.
16. Cauley JA, Eichner JE, Kamboh MI, Ferrell RE, Kuller LH. APOE allele frequencies in younger (age 42-50) versus older (age 65-90) women. Genet Epidemiol 1993;10:27-34.
17. Eggertsen G, Tegelman R, Ericsson S, Angelin B, Berglund L. Apolipoprotein E polymorphism in a healthy Swedish population: variation of allele frequency with age and relation to serum lipid concentrations. Clin Chem 1993;39:2125-2129.
18. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
19. Kuusi T, Nieminen MS, Enholm C, et al. Apolipoprotein E polymorphism and coronary artery disease: increased prevalence of apolipoprotein E-4 in angiographically defined coronary patients. Arteriosclerosis 1989;9:237-241.
20. van Bockxmeer FM, Mamotte CD. Apolipoprotein epsilon 4 homozygosity in young men with coronary heart disease. Lancet 1992;340:879-880.
21. Eichner JE, Kuller LH, Orchard TJ, et al. Relation of apolipoprotein E phenotype to myocardial infarction and mortality from coronary artery disease. Am J Cardiol 1993;71:160-165.
22. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA 1994;272:1666-1671.
23. Stengard JH, Zerba KE, Pekkanen J, Ehnholm C, Nissinen A, Sing CF. Apolipoprotein E polymorphism predicts death from coronary heart disease in a longitudinal study of elderly Finnish men. Circulation 1995;91:265-269.
24. Eto M, Watanabe K, Makino I. Increased frequencies of apolipoprotein E2 and E4 alleles in patients with ischemic heart disease. Clin Genet 1989;36:183-188.
25. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed rev. Washington DC, 1987.
26. Khachaturian ZS. Diagnosis of Alzheimer's disease. Arch Neurol 1985;42:1097-1105.
27. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadian E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-944.
28. Galasko D, Hansen LA, Katzman R, et al. Clinical-neuropathological correlations in Alzheimer's disease and related dementias. Arch Neurol 1994;51:888-895.
29. Joachim CL, Morris JH, Selkoe DJ. Clinically diagnosed Alzheimer's disease. Ann Neurol 1988;24:50-56.
30. Molsa PK, Palajarva L, Rinne JO, Rinne UK, Sako E. Validity of clinical diagnosis in dementia: a prospective clinicopathologic study. J Neurol Neurosurg Psychiatry 1985;48:1085-1090.
31. Olichney JM, Hofstetter CR, Galasko D, Thal LJ, Katzman R. Death certificate reporting of dementia and mortality in an Alzheimer's disease research center cohort. J Am Geriatr Soc 1995;43:1-4.
32. Galasko D, Saitoh T, Xia Y, et al. The apolipoprotein E allele ∈4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease. Neurology 1994;44:1950-1951.
33. Wenham PR, Price WH, Blundell G. Apolipoprotein E typing by one-stage PCR. Lancet 1991;337:1158-1159.
34. Hixson J, Vernier D. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage by Hha1. J Lipid Res 1991;31:545-548.
35. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
36. Kosunen O, Talasniemi S, Lehtovirta M, et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke 1995;26:743-748.
37. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-630.
38. Sparks DL, Hunsaker JC, Scheff SW, et al. Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease. Neurobiol Aging 1990;11:601-607.
39. Pedro-Botet J, Senti M, Nogues X, et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke. Roles of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke 1992;23:1556-1562.
40. Couderc R, Mahieux F, Bailleul S, Fenelon G, Mary R, Fermanian J. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study. Stroke 1993;24:661-664.
41. Shimano H, Ishibashi S, Murase T, et al. Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 1989;79:257-260.
42. Frisoni GB, Clalbresi L, Geroldi C, et al. Apolipoprotein E ∈4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-242.
43. Kawamata J, Tanaka S, Shimohano S, Ueda K, Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry 1994;57:1414-1416.
44. Wade JP, Mirsen TR, Hachinski VC, Fisman M, Lau C, Merskey H. The clinical diagnosis of Alzheimer's disease. Arch Neurol 1987;44:24-29.
45. Todorov AB, Go RC, Constantinidis J, Elston RC. Specificity of the clinical diagnosis of dementia. J Neurol Sci 1975;26:81-98.
46. Betard C, Robitaille Y, Gee M, et al. Apo E allele frequencies in Alzheimer's disease, Lewy body dementia, Alzheimer's disease with cerebrovascular disease and vascular dementia. Neuroreport 1994;5:1893-1896.
47. Payami H, Montee KR, Kaye JA, et al. Alzheimer's disease, apolipoprotein E4, and gender. JAMA 1994;271:1316-1317.
48. U.S. Department of Health and Human Services, Division of Vital Statistics. Monthly Vital Statistics Report, October 1994;42:17.
49. Weisgraber K, Pitas RE, Mahley RW. Lipoproteins, neurobiology, and Alzheimer's disease: structure and function of apolipoprotein E. Curr Opin Structural Biology 1994;4:507-515.